”The property is in very good condition and has great potential to be environmentally certified by, among other things, installing solar cells. There is also significant potential in utilizing existing building rights and build a large extension, which would increase the annual rent in the long term,” says Tommy Åstrand, CEO of SLP.

The property is acquired through a corporate transaction with planned access in May, conditional on the Swedish Strategic Products Inspectorate having made a decision to approve or leave the investment made through the acquisition without action. This is due to the fact that the existing tenant, through the warehousing of pharmaceutical, is considered to be carrying out activities worthy of protection according to the Act (2023:560) on the review of foreign direct investments.

The agreed property value amounts to SEK 268.5 million (EUR 24 million) and the transaction is financed with own funds.